Association of Changes in Transfusion Status with Changes in Health-Related Quality of Life of Real-World Patients with MDS Across Six Months of Treatment with Azacitidine
Chris L. Pashos(Oldham Council), Zeba M. Khan(Bristol-Myers Squibb (Switzerland)), David L. Grinblatt(NorthShore University HealthSystem), Gale Harding(Policy Analysis (United States)), Rami S. Komrokji(Moffitt Cancer Center), Thomas K. Street(Bristol-Myers Squibb (Switzerland)), Arlene S. Swern, Kristen Sullivan(Tufts University), Mikkael A. Sekeres(University of Miami), Mohit Narang(Gettysburg College)
Cited by 2
Related Papers
Development and first validation of the COPD Assessment Test
|European Respiratory Journal|2009|3.2k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k